The
following outstanding shares of common stock equivalents were excluded from the computation of the diluted net loss per share attributable
to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive.
Schedule of diluted net
loss per share attributed to common stock
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Stock options | |
| 6,255,575 | | |
| 4,202,154 | |
| Common stock warrants | |
| 1,763,570 | | |
| 1,763,570 | |
| Totals | |
| 8,019,145 | | |
| 5,965,724 | |
|